The introduction of nicotinamide like a nicotine alternative in e-cigarette and smokeless goods signifies a significant regulatory obstacle for the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to act as a sedative at high dosages6. The statements made by Nicotine River, ECBlend, and various vendors that their mer